Insider Transactions Reported by 14 Insiders of Processa Pharmaceuticals, Inc.

Symbol
PCSA on Nasdaq
Location
Vero Beach, FL

There are no Buy or Sell transactions made by insiders since 13 Feb 2025

Processa Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
James H. Stanker Chief Financial Officer $61,609 05 Apr 2024
Robert Michael Floyd Chief Operating Officer $51,618 09 Feb 2023
Sian Bigora Chief Development Officer $48,037 01 Jan 2026
David Young Pres. Research & Development, Director $44,354 01 Jan 2026
Patrick Lin Chief Business - Strategy Off $43,021 01 Jan 2026
Wendy Guy Chief Administrative Officer $42,792 01 Jan 2026
VIRGIL THOMPSON Director $42,163 27 Jun 2023
George K. Ng Chief Executive Officer, Director $31,668 01 Oct 2025
Yorke Justin W Director $11,248 01 Oct 2025
RUSSELL SKIBSTED Chief Financial Officer $5,880 01 Oct 2025
James R. Neal Director 01 Oct 2025
Khalid Islam Director 31 Mar 2022
Geraldine Pannu Director 01 Oct 2025
Khoso Baluch Director 01 Oct 2025

Recent Insider Transactions by Companies or Individuals for Processa Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.